Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CENTAURUS METALS LIMITED Share Issue/Capital Change 2017

May 30, 2017

64715_rns_2017-05-30_836d9057-f4f3-4cfc-b15a-05b0bcc6ed1c.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Appendix 3B New issue announcement

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

CENTAURUS METALS LIMITED

ABN

40 009 468 099

We (the entity) give ASX the following information.

Part 1 ‐ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1
+Class of+securities issued or to
be issued
2
Number of+securities issued or to
be issued (if known) or maximum
number which may be issued
3
Principal terms of the+securities
(e.g. if options, exercise price and
expiry
date;
if
partly
paid
+securities,
the
amount
outstanding and due dates for
payment;
if
+convertible
securities, the conversion price
and dates for conversion)
Unlisted options
74,000,000 unlisted options
The options are unquoted and have principal terms
as follows:
Tranche 1 – 18,500,000 options with an exercise
price of 1.3 cents each, vesting immediately and
expiring on 31 May 2020.
Tranche 2 – 18,500,000 options with an exercise
price of 1.4 cents each, vesting 31 May 2018 and
expiring on 31 May 2021.
Tranche 3 – 37,000,000 options with an exercise
price of 1.5 cents each, vesting 31 May 2019 and
expiringon 31 May2022.
  • See chapter 19 for defined terms.

Appendix 3B Page 1

Appendix 3B New issue announcement

4
Do the+securities rank equally in
all respects from the+issue date
with an existing+class of quoted
+securities?
If the additional+securities do not
rank equally, please state:
 the date from which they do
 the extent to which they
participate for the next
dividend, (in the case of a
trust, distribution) or interest
payment
 the extent to which they do
not rank equally, other than in
relation to the next dividend,
distribution or interest
payment
5
Issue price or consideration
6
Purpose of the issue
(If issued as consideration for the
acquisition of assets, clearly
identify those assets)
6a
Is the entity an+eligible entity that
has obtained security holder
approval under rule 7.1A?
If Yes, complete sections 6b – 6h
in relation to the+securities the
subject of this Appendix 3B, and
comply with section 6i
6b
The date the security holder
resolution under rule 7.1A was
passed
6c
Number of+securities issued
without security holder approval
under rule 7.1
Shares issued upon exercise of the options will rank
equally with existing fully paid ordinary shares on
issue.
Nil.
Issue of Options as approved by shareholders and
under the Company’s Employee Share Option Plan
(ESOP). The issue of options to directors were
approved by shareholders at the Annual General
Meeting held on 24 May 2017 and the ESOP was
approved by shareholders at the Annual General
Meeting on 31 May 2016. The purpose of the issue
of options to directors and employees is to provide
an ongoing incentive and retention tool for key
personnel within the organisation.
Yes
24 May 2017
Nil
  • See chapter 19 for defined terms.

Appendix 3B Page 2

Appendix 3B New issue announcement

6d
Number of+securities issued with
security holder approval under
rule 7.1A
6e
Number of+securities issued with
security holder approval under
rule 7.3, or another specific
security holder approval (specify
date of meeting)
6f
Number of+securities issued
under an exception in rule 7.2
6g
If+securities issued under rule
7.1A, was issue price at least 75%
of 15 day VWAP as calculated
under rule 7.1A.3? Include the
+issue date and both values.
Include the source of the VWAP
calculation.
6h
If+securities were issued under
rule 7.1A for non‐cash
consideration, state date on which
valuation of consideration was
released to ASX Market
Announcements
6i
Calculate the entity’s remaining
issue capacity under rule 7.1 and
rule 7.1A – complete Annexure 1
and release to ASX Market
Announcements
7
+Issue dates
Note: The issue date may be prescribed by ASX
(refer to the definition of issue date in rule
19.12). For example, the issue date for a pro rata
entitlement issue must comply with the
applicable timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
Nil
Nil
59,000,000 options issued to directors under
_Exception 14_pursuant to shareholder approval
received under Listing Rule 10.11 on 24 May 2017.
15,000,000 options issued to employee under
_Exception 9_pursuant to shareholder approved
ESOP.
N/A
N/A

Rule 7.1: 168,486,965

Rule 7.1A: 112,324,643
31 May 2017
  • See chapter 19 for defined terms.

Appendix 3B Page 3

Appendix 3B New issue announcement

88
Number and+class of all
+securities quoted on ASX
(including_the+securities in section
2 if applicable)
9
Number
and
+class
of
all
+securities not quoted on ASX
(_including

the
+securities
in
section 2 if applicable)
10
Dividend policy (in the case of a
trust, distribution policy) on the
increased capital (interests)
Number +Class
1,123,246,437
226,233,707
Fully paid ordinary
shares
Listed options with
exercise price of $0.01
and expiry date of 30
April 2018.
Number +Class
Unlisted Options – Refer
to Annexure 2
N/A

Part 2 ‐ Pro rata issue (Not Applicable)

Questions 11 to 33 are not applicable

Part 3 ‐ Quotation of securities

You need only complete this section if you are applying for quotation of securities

34 Type of[+] securities ( tick one )

(a) +Securities described in Part 1

(b)[All other ][+][securities ]

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities (Not Applicable)

Tick to indicate you are providing the information or documents

  • 35[If the ][+][securities are ][+][equity securities, the names of the 20 largest holders of the ] additional[+] securities, and the number and percentage of additional[+] securities held by those holders

36[If the ] +securities setting out the number of holders in the categories[+][securities are ][+][equity securities, a distribution schedule of the additional ] 1 ‐ 1,000

  • See chapter 19 for defined terms.

Appendix 3B Page 4

Appendix 3B New issue announcement

1,001 ‐ 5,000 5,001 ‐ 10,000 10,001 ‐ 100,000 100,001 and over

37[A copy of any trust deed for the additional ][+][securities ]

Entities that have ticked box 34(b)

Questions 38 to 42 are not applicable

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted[+] quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no‐one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

  • See chapter 19 for defined terms.

Appendix 3B Page 5

Appendix 3B New issue announcement

Sign here: Date: 31 May 2017 Company Secretary Print name: Paul Bridson == == == == ==

  • See chapter 19 for defined terms.

Appendix 3B Page 6

Appendix 3B New issue announcement

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

==> picture [415 x 411] intentionally omitted <==

----- Start of picture text -----

Insert number of fully paid [+] ordinary securities 529,667,912
on issue 12 months before the [+] issue date or
date of agreement to issue
Add the following:  77,201,276 issued on 21/06/16
• Number of fully paid [+] ordinary securities  52,798,724 issued on 21/06/16
issued in that 12 month period under an
 1,111,111 issued on 1/07/16
exception in rule 7.2
 10,000,000 issued on 28/07/16
• Number of fully paid [+] ordinary securities
issued in that 12 month period with  402,467,414 issued on 15/11/16
shareholder approval
 50,000,000 issued on 15/11/16
• Number of partly paid [+] ordinary securities
that became fully paid in that 12 month
period
Note:
• Include only ordinary securities here – other
classes of equity securities cannot be added
• Include here (if applicable) the securities the
subject of the Appendix 3B to which this
form is annexed
• It may be useful to set out issues of
securities on different dates as separate line
items
Subtract the number of fully paid [+] ordinary Nil
securities cancelled during that 12 month period
“A” 1,123,246,437
----- End of picture text -----

  • See chapter 19 for defined terms.

Appendix 3B Page 7

Appendix 3B New issue announcement

Step 2: Calculate 15% of “A”

Appendix 3B
New issue announcement
Appendix 3B
New issue announcement
Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply“A” by 0.15 168,486,965
Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has
already been used
Insertnumber of+equity securities issued or
agreed to be issued in that 12 month period
not counting_those issued:
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under rule
7.1 or rule 7.4
_Note:

• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable) the securities the
subject of the Appendix 3B to which this
form is annexed
• It may be useful to set out issues of
securities on different dates as separate line
items
“C” Nil
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity
under rule 7.1
“A” x 0.15
Note: number must be same as shown in Step 2
168,486,965
Subtract“C”
Note: number must be same as shown in Step 3
Nil
Total[“A” x 0.15] – “C” 168,486,965_[Note: this is the remaining_
placement capacity under rule 7.1]
  • It may be useful to set out issues of securities on different dates as separate line items

  • “C” Nil

Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1

under rule 7.1
“A” x 0.15 168,486,965
Note: number must be same as shown in Step 2
Subtract“C” Nil
Note: number must be same as shown in Step 3
Total[“A” x 0.15] – “C” 168,486,965_[Note: this is the remaining_
placement capacity under rule 7.1]
  • See chapter 19 for defined terms.

Appendix 3B Page 8

Appendix 3B New issue announcement

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

“A” 1,123,246,437 Note: number must be same as shown in Step 1 of Part 1 Step 2: Calculate 10% of “A” “D” 0.10 Note: this value cannot be changed Multiply “A” by 0.10 112,324,643

Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used

Insert number of[+] equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

Notes:

  • This applies to equity securities – not just ordinary securities

  • • Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed

  • Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

  • • It may be useful to set out issues of securities on different dates as separate line items

  • “E” 0

  • See chapter 19 for defined terms.

Appendix 3B Page 9

Appendix 3B New issue announcement

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A

Appendix 3B
New issue announcement
Appendix 3B
New issue announcement
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity
under rule 7.1A
“A” x 0.10
Note: number must be same as shown in Step 2
112,324,643
Subtract“E”
Note: number must be same as shown in Step 3
0
Total[“A” x 0.10] – “E” 112,324,643
  • See chapter 19 for defined terms.

Appendix 3B Page 10

Appendix 3B New issue announcement

Annexure 2

Securities Not Quoted on ASX ‐ Options Centaurus Metals Limited

Expiry date Exerciseprice Director & Employee
Options
Director & Employee
Options
Total number of
shares under
option
Vested Unvested
31/08/2018 $0.125 1,000,000 1,000,000 2,000,000
10/06/2018 $0.0082 5,500,000 5,500,000
10/06/2019 $0.0082 8,500,000 8,500,000
10/06/2020 $0.0082 8,500,000 8,500,000
31/05/2020 $0.013 18,500,000 18,500,000
31/05/2021 $0.014 18,500,000 18,500,000
31/05/2022 $0.015 37,000,000 37,000,000
Total 25,000,000 73,500,000 98,500,000
  • See chapter 19 for defined terms.

Appendix 3B Page 11